# Cell Lineage Affiliation During Hematopoiesis

**Authors:** Geoffrey Brown

PMC · DOI: 10.3390/ijms26073346 · 2025-04-03

## TL;DR

This review discusses how and when hematopoietic stem cells commit to specific blood cell lineages during development.

## Contribution

The paper reviews contrasting views on the timing and mechanism of lineage commitment in hematopoietic stem cells.

## Key findings

- There is uncertainty about when hematopoietic stem cells become affiliated with a single cell lineage.
- Two main views exist: late stepwise commitment or early continuous lineage affiliation.
- The review considers how much lineage-affiliated stem cells contribute to blood cell production.

## Abstract

By the mid-1960s, hematopoietic stem cells (HSCs) were well described. They generate perhaps the most complex array of functionally mature cells in an adult organism. HSCs and their descendants have been studied extensively, and findings have provided principles that have been applied to the development of many cell systems. However, there are uncertainties about the process of HSC development. They center around when and how HSCs become affiliated with a single-cell lineage. A longstanding view is that this occurs late in development and stepwise via a series of committed oligopotent progenitor cells, which eventually give rise to unipotent progenitors. A very different view is that lineage affiliation can occur as early as within HSCs, and the development of these cells to a mature end cell is then a continuous process. A key consideration is the extent to which lineage-affiliated HSCs self-renew to make a major contribution to hematopoiesis. This review examines the above aspects in relation to our understanding of hematopoiesis.

## Full-text entities

- **Genes:** Hoxb5 (homeobox B5) [NCBI Gene 15413] {aka Hox-2.1}, Cd48 (CD48 antigen) [NCBI Gene 12506] {aka BCM1, BLAST, BLAST-1, BLAST1, Bcm-1, MEM-102}, Kitl (kit ligand) [NCBI Gene 17311] {aka Clo, Con, Gb, Kitlg, Mgf, SCF}, Il11 (interleukin 11) [NCBI Gene 16156] {aka IL-11}, Spi1 (Spi-1 proto-oncogene) [NCBI Gene 20375] {aka Dis-1, Dis1, PU.1, Sfpi-1, Sfpi1, Spi-1}, Cd38 (CD38 antigen) [NCBI Gene 12494] {aka ADPRC 1, Cd38-rs1, I-19}, Csf3 (colony stimulating factor 3 (granulocyte)) [NCBI Gene 12985] {aka Csfg, G-CSF, MGI-IG}, Vwf (Von Willebrand factor) [NCBI Gene 22371] {aka 6820430P06Rik, B130011O06Rik, C630030D09, F8VWF, VWD}, Ly6g (lymphocyte antigen 6 family member G) [NCBI Gene 546644] {aka Gr-1, Gr1, Ly-6G}, Epo (erythropoietin) [NCBI Gene 13856], Gata1 (GATA binding protein 1) [NCBI Gene 14460] {aka Gata-1, Gf-1, eryf1}, Ly6a (lymphocyte antigen 6 family member A) [NCBI Gene 110454] {aka Ly-6A.2, Ly-6A/E, Ly-6E.1, Sca-1, Sca1, TAP}, Kit (Kit proto-oncogene receptor tyrosine kinase) [NCBI Gene 16590] {aka Bs, CD117, Fdc, Gsfsco1, Gsfsco5, Gsfsow3}, Csf2 (colony stimulating factor 2 (granulocyte-macrophage)) [NCBI Gene 12981] {aka CSF, Csfgm, GMCSF, Gm-CSf, MGI-IGM}, CD38 (CD38 molecule) [NCBI Gene 952] {aka ADPRC 1, ADPRC1, cADPR1}, Csf1 (colony stimulating factor 1 (macrophage)) [NCBI Gene 12977] {aka BAP025, Csfm, MCSF, Mhdabap25, PG-M-CSF, op}, Gata2 (GATA binding protein 2) [NCBI Gene 14461] {aka Gata-2}, Epor (erythropoietin receptor) [NCBI Gene 13857], Ly76 (lymphocyte antigen 76) [NCBI Gene 104231] {aka TER-119, Ter119}, Thy1 (thymus cell antigen 1, theta) [NCBI Gene 21838] {aka CD90, T25, Thy-1, Thy-1.2, Thy1.1, Thy1.2}, Itgam (integrin alpha M) [NCBI Gene 16409] {aka CD11b/CD18, CR3, CR3A, Cd11b, F730045J24Rik, Ly-40}, Cd34 (CD34 antigen) [NCBI Gene 12490], Il7r (interleukin 7 receptor) [NCBI Gene 16197] {aka CD127, IL-7Ralpha}, FLT3 (fms related receptor tyrosine kinase 3) [NCBI Gene 2322] {aka CD135, FLK-2, FLK2, STK1}, Slamf1 (signaling lymphocytic activation molecule family member 1) [NCBI Gene 27218] {aka 4933415F16, CD150, CDw150, ESTM51, IPO-3, Slam}, Thpo (thrombopoietin) [NCBI Gene 21832] {aka Mgdf, Ml, Mpllg, Tpo}, Flt3 (FMS-like tyrosine kinase 3) [NCBI Gene 14255] {aka B230315G04, CD135, Flk-2, Flk2, Flt-3, Ly72}, Il3 (interleukin 3) [NCBI Gene 16187] {aka BPA, Csfmu, HCGF, Il-3, MCGF, PSF}, Csf1r (colony stimulating factor 1 receptor) [NCBI Gene 12978] {aka CD115, CSF-1R, Csfmr, Fim-2, Fim2, Fms}, FLT3LG (fms related receptor tyrosine kinase 3 ligand) [NCBI Gene 2323] {aka FL, FLG3L, FLT3L, IMD125}, CD34 (CD34 molecule) [NCBI Gene 947], Itga6 (integrin alpha 6) [NCBI Gene 16403] {aka 5033401O05Rik, Cd49f, VLA-6}, Cd4 (CD4 antigen) [NCBI Gene 12504] {aka L3T4, Ly-4}, Il7 (interleukin 7) [NCBI Gene 16196] {aka A630026I06Rik, Il-7, hlb368}
- **Diseases:** injury to (MESH:D014947), inflammatory (MESH:D007249), platelet aggregation (MESH:D001791), Leukemia (MESH:D007938), Wiskott-Aldrich syndrome (MESH:D014923), metachromatic leukodystrophy (MESH:D007966), lymphoma (MESH:D008223), Lymphoproliferative disorders (MESH:D008232), beta-thalassemia (MESH:D017086), acute leukemias (MESH:D015470)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Caenorhabditis elegans (species) [taxon 6239], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** LSK — Homo sapiens (Human), Ehlers-Danlos syndrome, Finite cell line (CVCL_U778), ABLS8.1 — Mus musculus (Mouse), Mouse lymphoma, Cancer cell line (CVCL_RP70)

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11989489/full.md

---
Source: https://tomesphere.com/paper/PMC11989489